Print

PXVX-HIV-100-001

Phase I Study of Safety and Immunogenicity of Ad4-HIV Vaccine Vectors in Healthy Volunteers

Trial Details:

I Ongoing
PaxVax, National Institute of Allergy and Infectious Diseases (NIAID) October 15, 2013
Ad4-EnvC150,Ad4-mgag Replicating Ad4 Env C; Replicating Ad4 Gag
Ad4-mgag Viral Vector - Replicating
Ad4-EnvC150 Viral Vector - Replicating
USA 440
NCT01989533
http://www.clinicaltrials.gov/ct2/show/NCT01989533